BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12542844)

  • 1. Glucose-regulated glucose uptake by transplanted muscle cells expressing glucokinase counteracts diabetic hyperglycemia.
    Otaegui PJ; Ontiveros M; Ferre T; Riu E; Jiménez R; Bosch F
    Hum Gene Ther; 2002 Dec; 13(18):2125-33. PubMed ID: 12542844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of glucokinase in skeletal muscle: a new approach to counteract diabetic hyperglycemia.
    Otaegui PJ; Ferre T; Pujol A; Riu E; Jimenez R; Bosch F
    Hum Gene Ther; 2000 Jul; 11(11):1543-52. PubMed ID: 10945768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.
    Mas A; Montané J; Anguela XM; Muñoz S; Douar AM; Riu E; Otaegui P; Bosch F
    Diabetes; 2006 Jun; 55(6):1546-53. PubMed ID: 16731816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counteraction of type 1 diabetic alterations by engineering skeletal muscle to produce insulin: insights from transgenic mice.
    Riu E; Mas A; Ferre T; Pujol A; Gros L; Otaegui P; Montoliu L; Bosch F
    Diabetes; 2002 Mar; 51(3):704-11. PubMed ID: 11872670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of diabetic alterations by glucokinase.
    Ferre T; Pujol A; Riu E; Bosch F; Valera A
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7225-30. PubMed ID: 8692973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin receptor-overexpressing β-cells ameliorate hyperglycemia in diabetic rats through Wnt signaling activation.
    Kim MH; Hong SH; Lee MK
    PLoS One; 2013; 8(7):e67802. PubMed ID: 23874448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.
    Torres TP; Catlin RL; Chan R; Fujimoto Y; Sasaki N; Printz RL; Newgard CB; Shiota M
    Diabetes; 2009 Jan; 58(1):78-86. PubMed ID: 18952838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myostatin inhibition therapy for insulin-deficient type 1 diabetes.
    Coleman SK; Rebalka IA; D'Souza DM; Deodhare N; Desjardins EM; Hawke TJ
    Sci Rep; 2016 Sep; 6():32495. PubMed ID: 27581061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of a glucokinase point mutant in the treatment of diabetes mellitus.
    Lu G; Teng X; Zheng Z; Zhang R; Peng L; Zheng F; Liu J; Huang H; Xiong H
    Gene Ther; 2016 Apr; 23(4):323-9. PubMed ID: 26752353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele.
    Rossetti L; Chen W; Hu M; Hawkins M; Barzilai N; Efrat S
    Am J Physiol; 1997 Oct; 273(4):E743-50. PubMed ID: 9357804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased glucose disposal induced by adenovirus-mediated transfer of glucokinase to skeletal muscle in vivo.
    Jiménez-Chillarón JC; Newgard CB; Gómez-Foix AM
    FASEB J; 1999 Dec; 13(15):2153-60. PubMed ID: 10593862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated expression of glucokinase in the liver as an adjuvant treatment for type 1 diabetes.
    Morral N; McEvoy R; Dong H; Meseck M; Altomonte J; Thung S; Woo SL
    Hum Gene Ther; 2002 Sep; 13(13):1561-70. PubMed ID: 12228011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucokinase gene transfer to skeletal muscle of diabetic Zucker fatty rats improves insulin-sensitive glucose uptake.
    Jiménez-Chillarón JC; Telemaque-Potts S; Gómez-Valadés AG; Anderson P; Newgard CB; Gómez-Foix AM
    Metabolism; 2002 Jan; 51(1):121-6. PubMed ID: 11782883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.
    Dao LT; Park EY; Lim SM; Choi YS; Jung HS; Jun HS
    Transplantation; 2014 Nov; 98(10):1040-7. PubMed ID: 25208321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered enteroendocrine cells secrete insulin in response to glucose and reverse hyperglycemia in diabetic mice.
    Han J; Lee HH; Kwon H; Shin S; Yoon JW; Jun HS
    Mol Ther; 2007 Jun; 15(6):1195-202. PubMed ID: 17299398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential role for fructose-2,6-bisphosphate in the stimulation of hepatic glucokinase gene expression.
    Wu C; Okar DA; Stoeckman AK; Peng LJ; Herrera AH; Herrera JE; Towle HC; Lange AJ
    Endocrinology; 2004 Feb; 145(2):650-8. PubMed ID: 14617577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered K cells provide sufficient insulin to correct hyperglycemia in a nude murine model.
    Zhang Y; Yao L; Shen K; Xu M; Zhou P; Yang W; Liu X; Qin X
    Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):149-57. PubMed ID: 18235977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation of glucokinase in pancreatic beta-cells during acute and chronic hyperglycemia.
    Noma Y; Bonner-Weir S; Latimer JB; Davalli AM; Weir GC
    Endocrinology; 1996 Apr; 137(4):1485-91. PubMed ID: 8625927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutively active heat shock factor 1 enhances glucose-driven insulin secretion.
    Uchiyama T; Tomono S; Utsugi T; Ohyama Y; Nakamura T; Tomura H; Kawazu S; Okajima F; Kurabayashi M
    Metabolism; 2011 Jun; 60(6):789-98. PubMed ID: 20817212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.